Tag Archive for PRO/AH/EDR> COVID-19 update (537): clinical trial, South Asia, comment, WHO, global

PRO/AH/EDR> COVID-19 update (537): clinical trial, South Asia, comment, WHO, global

COVID-19 -- AfghanistanAbstract--------BackgroundSevere coronavirus disease 2019 (COVID-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known.MethodsWe conducted a double-blind, randomized, placebo-controlled trial evaluating baricitinib plus remdesivir in hospitalized adults with COVID-19. All the patients received remdesivir (10 days or less) and either baricitinib (14 days or less) or placebo Read more [...]